31 Annual Report 2022 Key Management Personnel Shareholdings At 30 June 2022 the interests of the key management personnel in the ordinary shares in the Company were: Balance Ordinary Shares 30 June 2021 Acquired via Share Purchase Plan Acquired on Market Balance Ordinary Shares 30 June 2022 Dr Geoffrey Cumming 125,093 19,354 32,967 177,414 Max Johnston 384,956 19,354 - 404,310 Philip Powell 267,277 19,354 110,000 396,631 Professor Allan Cripps - - - - Dr Leearne Hinch 30,000 19,354 25,000 74,354 Tony Di Pietro - - 5,000 5,000 Dr Gregory Rice - - - - Key Management Personnel Options Balance Options 30 June 2021 Acquired via Share Purchase Plan Granted as Remuneration Exercised Balance Options 30 June 2022 Dr Geoffrey Cumming 52,000 - 500,000 - 552,000 Max Johnston - - 500,000 - 500,000 Philip Powell - - 500,000 - 500,000 Professor Allan Cripps - - 500,000 - 500,000 Dr Leearne Hinch 666,667 9,677 - - 676,344 Tony Di Pietro 192,592 - - - 192,592 Dr Gregory Rice - - 150,000 - 150,000 Loans to Key Management Personnel There have been no loans to KMP’s during the financial year. Other Transactions with KMPs After ceasing his role as Chief Scientific Officer on 17 August 2021, Dr Peter French received $42,400 under a consultancy agreement during the reporting period, for strategic technology advice. There have been no other transactions with KMP’s during the financial year. Voting and comments at the Company’s 2021 Annual General Meeting The Company received 96.81% of the vote in favour of its Remuneration Report for the 2021 financial year. The Company did not receive any specific feedback at the AGMon its remuneration policies. ** ENDOF REMUNERATION REPORT **
RkJQdWJsaXNoZXIy MjE2NDg3